Legal & General Group »

Keros Therapeutics shares owned by Legal & General Group

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Legal & General Group from 13F filings

Historical chart of Legal & General Group investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Legal & General Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Legal & General Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $751k 19k 39.76
2023-09-30 $603k 19k 31.88
2023-06-30 $727k 18k 40.18
2023-03-31 $408k 9.5k 42.70
2022-12-31 $388k 8.1k 48.02
2022-09-30 $287k 7.6k 37.53
2022-06-30 $191k 6.9k 27.66
2022-03-31 $373k 6.9k 54.46
2021-12-31 $360k 6.2k 58.46
2021-09-30 $243k 6.1k 39.59
2021-06-30 $154k 3.6k 42.45
2021-03-31 $211k 3.4k 61.81
2020-12-31 $245k 3.5k 70.48
2020-09-30 $32k 838 38.19
2020-06-30 $42k 1.1k 37.23